Agilon Health Inc Revenue Growth Rates (AGL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Agilon Health Inc   (NYSE: AGL)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

AGL's Revenue Growth by Quarter and Year

Agilon Health Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AGL/growth
https://api.csimarket.com/api/v1/companies/AGL/fundamentals
https://api.csimarket.com/api/v1/companies/AGL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
AGL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1,519.49
2nd Quarter June 1,494.74
1st Quarter March 1,420.46
FY 4,434.69

AGLs Annual Revenue
Agilon Health Inc 's Revenue in the fiscal year 2025 $ 5,932.58 millions
Agilon Health Inc 's Revenue in the fiscal year 2024 $ 6,060.53 millions
Agilon Health Inc 's Revenue in the fiscal year 2023 $ 4,316.36 millions
Agilon Health Inc 's Revenue in the fiscal year 2022 $ 2,708.21 millions
Agilon Health Inc 's Revenue in the fiscal year 2021 $ 1,833.56 millions




AGL Revenue third quarter 2026 Y/Y Growth Comment
Agilon Health Inc reported Revenue growth of 5.86% year on year in the third quarter 2026, to $ 1,519.49 millions, this is lower than Agilon Health Inc 's recent average Revenue improvement of 36.46%.

Looking into third quarter 2026 results within Healthcare Facilities industry 14 other companies have achieved higher Revenue growth. While Agilon Health Inc ' s Revenue increase of 5.86% ranks overall at the positon no. 2041 in the third quarter 2026.


AGL Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 5.86 %
2nd Quarter June 7.15 %
1st Quarter March -7.33 %
FY   -

Financial Statements
Agilon Health Inc 's third quarter 2026 Revenue $ 1,519.49 millions AGL's Income Statement
Agilon Health Inc 's third quarter 2025 Revenue $ 1,435.32 millions Quarterly AGL's Income Statement


AGL Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1.66 %
2nd Quarter June 5.23 %
1st Quarter March -9.5 %
FY (Year on Year)   -


Back to AGL Growth rate Comparisons >> Back to AGL Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #15
Healthcare Sector #309
Overall #2041

Revenue Y/Y Growth Statistics
High Average Low
86.69 % 36.46 % -7.33 %
(Sep 30 2023)   (Mar 31 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #15
Healthcare Sector #309
Overall #2041
Revenue Y/Y Growth Statistics
High Average Low
86.69 % 36.46 % -7.33 %
(Sep 30 2023)   (Mar 31 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Agilon Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
96.73 % 9.17 % -32.92 %
(Mar 31 2024)  


AGL's III. Quarter Q/Q Revenue Comment
Agilon Health Inc achieved in the III. Quarter 2026 below company average Revenue growth of 1.66% quarter on quarter, to $ 1,519.49 millions.

Within Healthcare Facilities industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Agilon Health Inc 's Revenue growth quarter on quarter, overall rank is 1130.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #10
Healthcare Sector #165
Overall #1130
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #10
Healthcare Sector #165
Overall #1130
Revenue Q/Q Growth Statistics
High Average Low
96.73 % 9.17 % -32.92 %
(Mar 31 2024)  


AGL's III. Quarter Q/Q Revenue Comment
Agilon Health Inc achieved in the III. Quarter 2026 below company average Revenue growth of 1.66% quarter on quarter, to $ 1,519.49 millions.

Within Healthcare Facilities industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Agilon Health Inc 's Revenue growth quarter on quarter, overall rank is 1130.


Agilon Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 5,920.01
Y / Y Revenue Growth (TTM) 0.32 %
Year on Year Revenue Growth Overall Ranking # 1086
Seqeuential Revenue Change (TTM) 1.71 %
Seq. Revenue Growth (TTM) Overall Ranking # 2771


Cumulative Revenue growth Comment
Although Agilon Health Inc 's Annual Revenue growth year on year were below company's average 36.52% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.32% year on year, from -2.82% in Mar 31 2026.

In the Healthcare sector 205 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 345 to 1086.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 29
Healthcare Sector # 206
Overall # 1086

Revenue TTM Y/Y Growth Statistics
High Average Low
68.89 %
 36.52 %
-2.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 390
S&P 500 # 2771
Cumulative Revenue growth Comment
Although Agilon Health Inc 's Annual Revenue growth year on year were below company's average 36.52% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.32% year on year, from -2.82% in Mar 31 2026.

In the Healthcare sector 205 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 345 to 1086.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 29
Healthcare Sector # 206
Overall # 1086

Revenue TTM Y/Y Growth Statistics
High Average Low
68.89 %
36.52 %
-2.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 390
S&P 500 # 2771




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AGL's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Livanova Plc10.17%$ 10.170 millions
Kura Oncology Inc 10.07%$ 10.067 millions
Amneal Pharmaceuticals Inc 10.04%$ 10.040 millions
Quest Diagnostics Inc9.98%$ 9.979 millions
Idexx Laboratories Inc9.95%$ 9.950 millions
Bausch Health Companies Inc 9.70%$ 9.698 millions
Marpai Inc9.59%$ 9.586 millions
Haemonetics Corporation9.49%$ 9.492 millions
Progyny Inc 9.08%$ 9.084 millions
Ironwood Pharmaceuticals inc 9.00%$ 8.996 millions
Encompass Health Corporation8.93%$ 8.934 millions
West Pharmaceutical Services Inc 8.73%$ 8.728 millions
Resmed Inc 8.67%$ 8.667 millions
Carlisle Companies Incorporated8.65%$ 8.649 millions
Concentra Group Holdings Parent Inc 8.61%$ 8.611 millions
Merit Medical Systems Inc8.56%$ 8.563 millions
Medpace Holdings Inc 8.50%$ 8.501 millions
Pulmonx Corporation8.47%$ 8.470 millions
Amgen Inc 8.45%$ 8.455 millions
Precipio inc 8.33%$ 8.335 millions
Fulgent Genetics Inc 8.26%$ 8.262 millions
Amphastar Pharmaceuticals Inc 8.22%$ 8.219 millions
Ultragenyx Pharmaceutical Inc 8.17%$ 8.170 millions
Baxter International Inc 8.08%$ 8.078 millions
Tactile Systems Technology Inc 8.07%$ 8.067 millions
Iqvia Holdings Inc 8.00%$ 8.000 millions
Exagen Inc 7.86%$ 7.859 millions
Gyre Therapeutics Inc 7.75%$ 7.754 millions
Stryker Corp7.64%$ 7.644 millions
Bausch and Lomb Corp7.34%$ 7.338 millions


About Agilon Health Inc Revenue Growth Rates (AGL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Agilon Health Inc (CIK 1831097).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-070141
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Agilon Health Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.